AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05503537 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Static stretching
Description: Static stretching will be performed by asking patient to perform dorsiflexion till the point of discomfort. The patient will hold the stretch for 15 second and 5 repetitions will be performed.
Study NCT05211622 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 1. alpha acid lipoic - tables
Description: 600 mg/die per os from 7 days before the beginning of chemotherapy and continue for other 4 days
Study NCT05211622 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 1. alpha acid lipoic - tables
Description: 600 mg/die per os from 7 days before the beginning of chemotherapy and continue for other 4 days
Study NCT05211622 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 2. ozonated oil - mouthwash
Description: 1 minute- three times/die after oral hygiene, possibly, from the beginning of chemotherapy and for 2 weeks
Study NCT05211622 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 2. ozonated oil - mouthwash
Description: 1 minute- three times/die after oral hygiene, possibly, from the beginning of chemotherapy and for 2 weeks
Study NCT05211622 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 3. chlorhexidine 0,2% - mouthwash
Description: 1 minute- three times/die after oral hygiene, possibly, from five days after the beginning of chemotherapy and for subsequent 2 weeks
Study NCT05211622 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 3. chlorhexidine 0,2% - mouthwash
Description: 1 minute- three times/die after oral hygiene, possibly, from five days after the beginning of chemotherapy and for subsequent 2 weeks
Study NCT05211622 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: 4. sodium bicarbonate 5% solution - mouthwash
Description: 1 minute- three times/die after oral hygiene, possibly, from the beginning of chemotherapy and for 3 weeks
Study NCT05907356 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: sciatic nerve slider technique in slump lying position
Description: The patient will be sitting at the edge of the couch with the posterior aspect of the knee at the edge, the thighs parallel to each other, and flexion at the thoracic and lumbar spines (slouch position). The therapist will be standing at the bedside of the patient with a proximal arm over the patient's shoulder and one hand guiding the neck movements of the patient and the other hand guiding the knee movements, passively performing cervical neck flexion with knee flexion (stretching the nerve proximally and relaxing at the distal end) and then moving into cervical extension with knee extension. Provide five sets in every session: the first: 10 repetitions, the second: 15 repetitions, the third: 20 repetitions, the fourth: 25 repetitions; and the fifth: 30 repetitions. The end position is held for 5 seconds, and the rest between sets is 1-2 minutes
Study NCT05907356 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: sciatic nerve slider technique in supine position
Description: .The patient will be in a supine position. The therapist will hold the patient's limb passively and then move the hip into flexion with the ankle in plantar flexion and the knee in extension, stretching the nerve at the hip and relaxing at the ankle, Then reversing the movement with the hip into extension, maintaining the knee in extension and the ankle in dorsiflexion, relaxing the nerve at the hip and stretching at the ankle. Provide five sets in every session; the first: 10 repetitions, the second: 15 repetitions, the third: 20 repetitions, the fourth: 25 repetitions, and the fifth: 30 repetitions. The end position is held for 5 seconds, and the rest between sets is 1-2 minutes.
Study NCT05907356 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional physiotherapy
Description: The patient will receive conventional physiotherapy, which includes: a moist hot pack, TENS, and back strengthening exercises (as a home program).
Study NCT06568146 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Multivitamin Supplement
Description: : Participants will take 2 capsules of the multivitamin supplement daily with the first meal of the day in the morning.
Study NCT06142201 — intervention group
Intervention type: DRUG
Intervention: JT001
Description: oral administration
Study NCT05913063 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Structured Light Imaging Microscopy
Description: Conducting the psychophysical task on the perception of OAM-coupled polarized light created using the experimental setup - Structured Light Imaging Microscopy (SLIM). Four types of vortex orbital angular momentum, differing by the number of fringes l=5;10; 15;20, will be presented for 0.5s per trial during which an azimuthally varying entoptic profile rotated clockwise or counterclockwise. A circular mask with a varying radius will be placed at fixation, thus the task will be performed at varying eccentricities. Circular obstruction of the area will be achieved due to the high refresh-rate structured light modulator. The threshold mask size will be changed by a 2up/1down staircase method (71% accuracy for the estimation of mask size).
Study NCT04666038 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LOXO-305
Description: Oral LOXO-305
Study NCT04666038 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Idelalisib
Description: Oral
Study NCT04666038 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bendamustine
Description: IV
Study NCT04666038 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rituximab
Description: IV
Study NCT06537323 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Femoral nerve block with0.25% bupivacaine guided by ultrasound.
Description: Femoral nerve block with0.25% bupivacaine guided by ultrasound.
Study NCT06532227 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: No intervention excepted data collection
Study NCT06537323 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: PENG block with0.25% bupivacaine guided by ultrasound.
Description: PENG block with0.25% bupivacaine guided by ultrasound.
Study NCT06537323 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Preoperative IV fentanyl 100microgram
Description: Preoperative IV fentanyl 100microgram
Study NCT04609319 — intervention group
Intervention type: DRUG
Intervention: Dacomitinib
Description: This is a non-interventional, real world study of Asian patients being treated with dacomitinib as first-line treatment for EGFR+ NSCLC
Study NCT06147505 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: XS005 Injection
Description: Treatment on this study includes XS005 infusions over an 16 week period. Phase 1： dose escalation (3+3); Phase 2 : dose of recommended phase 2 dose(RP2D).
Study NCT04794725 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Blood sampling
Description: blood samples from venepuncture (10mL)
Study NCT05150197 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: VisuALL
Description: Virtual Reality Visual Field Device
Study NCT05150197 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: VisuALL
Description: Virtual Reality Visual Field Device
Study NCT05150197 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Humphrey Visual Field
Description: Standard of care Visual Field test
Study NCT05032573 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Olive oil and Dietary Guideline recommendations
Description: 60 mL of olive oil and healthy diet recommendations
Study NCT05032573 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Dietary Guideline recommendations
Description: healthy diet recommendations
Study NCT05725473 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Eso-Flip
Description: Dilatation with Eso-FLIP
Study NCT05249725 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Irsogladine Maleate
Description: Orally administration of irsogladine maleate 4mg/day, for 8 weeks.
Study NCT06393907 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hemostatic Forceps
Description: The experimental device will be used for control bleeding in high risk gastroduodenal ulcers.
Study NCT06393907 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Bipolar Electrocautery Probes
Description: The active comparator devices will be used for control bleeding in high risk gastroduodenal ulcers.
Study NCT05249725 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Hydrotalcite
Description: Patients were given 1 g hydrotalcite every morning, afternoon and evening for 8 weeks.
Study NCT06404996 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Smart-phone Voiding Diary
Description: Smart-phone Voiding Diary
Study NCT06404996 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Paper voiding diary
Description: Conventional Paper voiding diary
Study NCT05795023 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: NeuraLight
Description: NeuraLight software-based platform
Study NCT04977843 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: EARLY BRONCHOALVEOLAR LAVAGE
Description: E-BAL done with instillation of 100cc normal saline and sucked out
Study NCT05557968 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Therapy
Description: conventional therapy will be given for stroke patients and three assessments i.e. pre, post and follow up surveys, a session of 30 minutes, 3 times weekly for a six week period.~Total 18 sessions would be performed on each patient for six weeks
Study NCT05557968 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Action Observation Therapy (AO)
Description: The video consists of :~1. Ascending and descending the step box.~2. Ascending and descending the stairs in the treatment room.~3. Holding the handrails to climb and descend the stairs inside and outside the building.~4. Climbing and descending the stairs inside and outside the building without holding the handle.~5. Climbing and descending the sidewalk block
Study NCT05267171 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Web access
Description: The intervention group will have access to the website where the information is provided. The control group will not have this access.
Study NCT05503537 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Basic Cardiac Rehabilitation Protocol
Description: Ankle pumps, leg slides, walking
Study NCT05503537 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Basic Cardiac Rehabilitation Protocol
Description: Ankle pumps, leg slides, walking
Study NCT04903691 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cardiac Exercise Program
Description: Participants who enrolled in cardiac exercise program
Study NCT05596526 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: recombinant zoster vaccine
Description: Shingrix® vaccine will be administered in two vaccinations on Day0 and Day60
Study NCT05495412 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Rebound therapy
Description: Exercise therapy delivered twice weekly for 6 weeks, during Phase B of an ABA single case study design.
Study NCT06721117 — intervention group
Intervention type: OTHER
Intervention: Pain threshold assessment
Description: Pain sensitivity to pressure will be assessed with a pain measuring device called an algometer. The Baseline Dolorimeter brand algometer will be used in the assessment. 3 measurements will be taken from the midpoint of the upper trapezius muscle and C7 points between the lateral edge of the acromion and C7. The areas will be marked before the measurement. The algometer will be placed perpendicular to these points. The patients will be asked to report the moment they first felt the pain and 30 seconds of rest will be given between the measurements. The value on the display will be read and the pain threshold will be recorded in pounds (1kg=2.2 pounds).
Study NCT06721117 — intervention group
Intervention type: OTHER
Intervention: Anxiety level assessment
Description: The anxiety level will be determined with the Beck Anxiety Inventory. The Beck Anxiety Inventory is a scale developed by Aaron T. Beck (1988). This scale consists of 21 questions. For each item, the patient is asked to report how he/she has felt during the past week.~The items are scored as 0, 1, 2 or 3. The score range is between 0-63. For the total score, \< 21 is considered mild, 22-35 is considered moderate, and > 36 is considered severe. The Turkish validity study of the Beck anxiety scale was conducted by Ulusoy et al (1996).
Study NCT06720025 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SAL-0951 tablets
Description: initial phase：4mg QD subsequent phase：1mg～8mg QD，adjust the dose based on hemoglobin concentration level every 4 weeks
Study NCT06720025 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: rHuEPO injection
Description: Initial based on the original rHuEPO dose adjust the dose based on hemoglobin concentration level every 4 weeks
Study NCT06721390 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Piano Improvisation
Description: Piano Improvisation taught by a professional instructor for 12 weeks.
Study NCT06721390 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Music Listening
Description: Music Listening facilitated by a professional instructor for 12 weeks.
Study NCT06317870 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Intrathecal morphine
Description: Spinal anesthesia will be performed as follows: patient will be placed in the lateral decubitus position on the non-operative side. Using sterile gloves red chlorhexidine 2% alcohol solution will be used for skin disinfection. The site will be secured with a sterile drape, and the L4-L5 lumbar space identified. After subcutaneous local infiltration with 1% lidocaine, a 25G Whitacre pencil point spinal needle will be used to access the intrathecal space with free flow of cerebrospinal fluid as confirmation. A mixture of 12.5 mg of isobaric bupivacaine and 100 mcg of morphine will be administered intrathecally.~After the spinal anesthesia, the intrathecal morphine (ITM) group will receive a sham PENG block with the block needle inserted subcutaneously, the anesthesiologist using the same verbal block confirmation commands aspirate, inject but the needle withdrawn without injection. This will create the appearance of an identical cutaneous injection site to ensure patient blinding.
Study NCT06317870 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pericapsular nerve group block (PENG)
Description: Spinal anesthesia with intrathecal injection of 12.5 mg of isobaric bupivacaine will be performed, followed by a PENG block.~After skin disinfection, a low frequency curvilinear ultrasound probe (2-5 MHz 8870, BK ultrasound, Peabody Massachussets, US) with a sterile covering will be used to identify the anterior inferior iliac spine, the pubic eminence and the psoas tendon with its fascial plane. A 22 gauge 10cm block needle (Sonoplex® Pajunk, Geisingen, DE), will be used to enter the fascial plane and 20ml of 0.75% Ropivacain (Fresenius Kabi, Krienz CH) will be injected.
Study NCT05435027 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GRT-R912, samRNA-Spikebeta-TCE11
Description: IM injection of GRT-R912. Doses will be decided after safety review of Part A.
Study NCT05963854 — intervention group
Intervention type: OTHER
Intervention: Survey Curbside
Description: Observational. Waste will be collected on specific days for 2 consecutive weeks and surveys will be completed to coincide with the waste collections.
Study NCT04822246 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Control: Hand instrumentation for caries excavation
Description: An enamel hatchet will be used to create access to the carious lesion and then removal of soft carious tissue will be undertaken with excavators. Excavation will be stopped when some resistance to excavation will be felt and the cavity will be then conditioned with polyacrylic acid for 20 s, washed and dried with cotton pellets. A high-viscosity glass-ionomer cement will be used to restore the cavity. Moisture control will be achieved with the use of cotton wool rolls. A chair-side assistant will hand-mix the glass-ionomer according to manufacturers' instructions and it will be placed in the cavity using the press-finger technique whenever the type of cavity allows it. In the case of root restorations, a glove coated with petroleum jelly will be used similarly to the press-finger technique to better condense the material into the cavity. Excess material will be removed; the restoration will be coated with petroleum jelly. No local anaesthetic will be used to provide ART treatment.
Study NCT04822246 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intervention 1: EMS Airflow device for caries excavation
Description: An enamel hatchet will first be used to gain access into the cavity. Then the powder-water prophylaxis device will be used for the removal of soft carious tissue with the sodium bicarbonate powder-water jet. Excavation will be stopped when the colour of the lesion begins to darken and all the soft deposits are evacuated. The excavation will be done intermittently allowing sufficient time to check with hand instrument the surface hardness of the lesion. If the lesion is still soft excavation will be continued until the surface is hard suitable for restoring. The cavity will be then rinsed with copious water spray to evacuate all the powder-water material. The restoration procedure with a glass-ionomer cement will be done following the same procedures as in the control group.
Study NCT06701786 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Compressive Sutures (CSs) group
Description: The extent of the depth of the recession will be reported on the anatomical papillae and, after adding 1mm, 2 horizontal incisions of approximately 3mm will be made at the base of the surgical papillae laterally to the recession.Two divergent releasing incisions will be made extending approximately 2-3mm into the alveolar mucosa.The surgical papillae will be detached in partial thickness. A full thickness dissection will be performed from the bottom of the recession to expose approximately 3mm of the crest bone.A partial thickness dissection will be performed in the most apical portion of the flap until complete passivation of the flap is obtained.The harvesting of the epithelial-connective graft will be performed . The de-epithelialised graft will be sutured at the level of the de-epithelialised anatomical papillae; then the flap will be repositioned coronally suturing the anatomical papillae on the surgical ones. Three compressive sutures will be placed on the repositioned flap.
Study NCT06701786 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Without Compressive Sutures (WCSs) group
Description: The extent of the depth of the recession will be reported on the anatomical papillae and, after adding 1 mm, 2 horizontal incisions of approximately 3 mm will be made at the base of the surgical papillae laterally to the recession.Two divergent releasing incisions will be made extending approximately 2-3 mm into the alveolar mucosa.The surgical papillae will be detached in partial thickness. A full thickness dissection will be performed from the bottom of the recession to expose approximately 3mm of the crest bone.A partial thickness dissection will be performed in the most apical portion of the flap until complete passivation of the flap is obtained.The harvesting of the epithelial-connective graft will be performed. The de-epithelialised graft will be sutured at the level of the de-epithelialised anatomical papillae; than then the flap will be repositioned coronally suturing the anatomical papillae on the surgical ones.
Study NCT06632990 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BMS-984923
Description: oral capsules once or twice daily
Study NCT06632990 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Midazolam
Description: midazolam, oral, 2mg administered before study drug and after study drug
Study NCT06632990 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Caffeine
Description: Caffeine, oral, 100mg administered before study drug and after study drug
Study NCT06632990 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: dextromethorphan
Description: dextromethorphan, oral, 30mg administered before study drug and after study drug
Study NCT06700642 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Educational intervention
Description: In this study, 3 intervention tools were developed by the researchers. The first of these, 'Rational Drug Use Trainer Guide', was used for trainer training and standardisation of the education given to patients. The sample rational drug use presentations prepared by the Ministry of Health, Turkiye Medicines and Medical Devices Agency, Department of Rational Drug Use were combined in terms of content, enriched with information obtained from the literature and developed for the use of family physicians working in primary health care institutions in their clinical practices.~'Rational Drug Use Individual Education Presentation' was prepared by the researchers in line with the 'Rational Drug Use Trainer Guide'. It has been prepared in a format suitable for individual education presentation with the most concise and understandable content suitable for use during primary healthcare service delivery.~'Rational Drug Use Patient Brochure' was prepared by the researchers in a similar content.
Study NCT04541758 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: surgical treatment
Description: surgical treatment and Conservative treatment
Study NCT04541758 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Conservative treatment
Description: Conservative treatment
Study NCT05435027 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GRT-R914, samRNA-Spikebeta-TCE9
Description: Part A: 3 microgram (mcg), 10 mcg, or 30 mcg intramuscular (IM) injection of GRT-R914.~Part C: IM injection of GRT-R914. Doses decided after safety review of Part A.
Study NCT05435027 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GRT-R918, samRNA-SpikeOmicron-N-TCE11
Description: IM injection of GRT-R918. Doses will be decided after safety review of Part A.